FDA Adverse Event Malfunction Summary report: N

BD VACUTAINER® PST¿ GEL AND LITHIUM HEPARINN (LH) BLOOD COLLECTION TUBE

MDR report key: 13863009 · Received March 23, 2022

Report

Report Number
1917413-2022-00152
Event Type
Malfunction
Date Received
March 23, 2022
Date of Event
March 2, 2022
Report Date
June 6, 2022
Manufacturer
BECTON, DICKINSON & CO. (BROKEN BOW)
Product Code
JKA
UDI-DI
50382903679602
PMA / PMN Number
K945952
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

DATE OF EVENT: UNKNOWN. THE DATE RECEIVED BY MANUFACTURER HAS BEEN USED FOR THIS FIELD. THERE WERE MULTIPLE LOT NUMBERS REPORTED TO BE INVOLVED. THE INFORMATION FOR EACH LOT NUMBER IS AS FOLLOWS: MEDICAL DEVICE LOT #: 1319265. MEDICAL DEVICE EXPIRATION DATE: 30-NOV-2022. DEVICE MANUFACTURE DATE: 15-NOV-2021. MEDICAL DEVICE LOT #: 1040986. MEDICAL DEVICE EXPIRATION DATE: 28-FEB-2022. DEVICE MANUFACTURE DATE: 09-FEB-2021. A DEVICE EVALUATION IS ANTICIPATED BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

Additional Manufacturer Narrative · 0

THE FOLLOWING FIELDS HAVE BEEN UPDATED: D9: DEVICE AVAILABLE FOR EVAL? NO. D9: RETURNED TO MANUFACTURER ON: BLANK. H.6 INVESTIGATION SUMMARY: MATERIAL #: 367960; LOT/BATCH #: 1319265, 1040986. BD HAD NOT RECEIVED SAMPLES OR PHOTOS FOR EVALUATION. THEREFORE, RETENTION SAMPLES OF THE INCIDENT LOT WERE SELECTED FROM BD INVENTORY FOR EVALUATION AND UPON COMPLETION, NO ISSUES RELATING TO ERRONEOUS RESULTS WERE OBSERVED. NO DIFFICULTIES WERE ENCOUNTERED DURING BLOOD COLLECTION AND ALL TUBES APPEARED TO EXHIBIT PROPER FILL. BD WAS UNABLE TO CONFIRM THE CUSTOMER¿S INDICATED FAILURE (ERRONEOUS RESULTS) BECAUSE THE DEFECT WAS NOT EVIDENT IN THE TESTING OF THE COMPLAINT LOT SAMPLES. REPLICATES OF BOTH RETAIN AND CONTROL SAMPLES TESTED WERE ACCEPTABLE IN TERMS OF BOTH PRECISION AND ACCURACY (VALIDATION ATTACHED). ALL SAMPLES (RETAIN AND CONTROL LOTS) DEMONSTRATED CLINICALLY ACCEPTABLE PERFORMANCE FOR ALL VISUAL OBSERVATIONS EVALUATED. ALL TUBES PERFORMED AS EXPECTED. BASED ON A REVIEW OF THE DEVICE HISTORY RECORD FOR THE INCIDENT LOT, ALL PRODUCT SPECIFICATIONS AND REQUIREMENTS FOR LOT RELEASE WERE MET. THERE WERE NO RELATED QUALITY ISSUES DURING MANUFACTURING OF THE PRODUCT. THIS COMPLAINT IS UNABLE TO BE CONFIRMED FOR THE INDICATED FAILURE MODE ERRONEOUS RESULTS. BD WAS NOT ABLE TO IDENTIFY A ROOT CAUSE FOR THE INDICATED FAILURE MODE. FACTORS THAT MAY CONTRIBUTE TO ERRONEOUS RESULTS WERE EVALUATED THROUGH A CLINICAL STUDY TO VERIFY THE DESIGN OF THE DEVICE MET IT¿S INTENDED USE. THE RESULT OF THE STUDY SHOWED THAT THE DEVICE PERFORMED AS EXPECTED AND WE WERE UNABLE TO DETERMINE ANY EXTERNAL CONTRIBUTOR TO THIS REPORTED ISSUE. COMPLAINTS RECEIVED FOR THIS DEVICE AND REPORTED CONDITION WILL CONTINUE TO BE TRACKED AND TRENDED. OUR BUSINESS TEAM REGULARLY REVIEWS THE COLLECTED DATA FOR IDENTIFICATION OF EMERGING TRENDS.

Description of Event or Problem · 0

IT WAS REPORTED THAT 1 BD VACUTAINER® PST¿ GEL AND LITHIUM HEPARINN (LH) BLOOD COLLECTION TUBE EACH FROM LOTS 1319265 AND 1040986 PRODUCED ERRONEOUS LEUKEMIA READINGS ON THE PLASMA. THERE WAS NO INDICATION OF CONFIRMATORY TESTING, OR THAT RESULTS WERE REPORTED TO CLINICIANS. THERE WAS ALSO NO REPORT OF PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: "CUSTOMER STATES THAT SHE RECEIVED DISCREPANT RESULTS WITH TWO TUBES ON FRIDAY, ONE ON MONDAY, AND ONE YESTERDAY EVENING. SHE STATES THAT THEY ARE GETTING HIGHER READINGS ON PLASMA ON THE LEUKEMIA READING. SHE STATES THAT THE LAB THEY'RE GETTING THE TUBES FROM ARE WAITING TO CENTRIFUGE WHEN IT CLOTS" "CUSTOMER EXPLAINED THEY ARE VALIDATING THE PST TUBE AND RUNNING AN SST TUBE AND PST TUBE ON THE ROCHE PRO C503 AND MOST OF THE PST TUBES ARE COMING UP WITH HIGH LIPEMIA LEVELS VS THE SST WITH NO LIPEMIA LEVEL. THE TUBES ARE DRAWN, CENTRIFUGED AND TRANSPORTED TO THE LAB FOR TESTING. SHE STATES THAT THE PLASMA OF PST TUBES APPEARS CLEAR."

Description of Event or Problem · 0

IT WAS REPORTED THAT 1 BD VACUTAINER® PST¿ GEL AND LITHIUM HEPARINN (LH) BLOOD COLLECTION TUBE EACH FROM LOTS 1319265 AND 1040986 PRODUCED ERRONEOUS LEUKEMIA READINGS ON THE PLASMA. THERE WAS NO INDICATION OF CONFIRMATORY TESTING, OR THAT RESULTS WERE REPORTED TO CLINICIANS. THERE WAS ALSO NO REPORT OF PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: "CUSTOMER STATES THAT SHE RECEIVED DISCREPANT RESULTS WITH TWO TUBES ON FRIDAY, ONE ON MONDAY, AND ONE YESTERDAY EVENING. SHE STATES THAT THEY ARE GETTING HIGHER READINGS ON PLASMA ON THE LEUKEMIA READING. SHE STATES THAT THE LAB THEY'RE GETTING THE TUBES FROM ARE WAITING TO CENTRIFUGE WHEN IT CLOTS" "CUSTOMER EXPLAINED THEY ARE VALIDATING THE PST TUBE AND RUNNING AN SST TUBE AND PST TUBE ON THE ROCHE PRO C503 AND MOST OF THE PST TUBES ARE COMING UP WITH HIGH LIPEMIA LEVELS VS THE SST WITH NO LIPEMIA LEVEL. THE TUBES ARE DRAWN, CENTRIFUGED AND TRANSPORTED TO THE LAB FOR TESTING. SHE STATES THAT THE PLASMA OF PST TUBES APPEARS CLEAR."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1021477 BD VACUTAINER® PST¿ GEL AND LITHIUM HEPARINN (LH) BLOOD COLLECTION TUBE BLOOD SPECIMEN COLLECTION DEVICE JKA BECTON, DICKINSON & CO. (BROKEN BOW) 367960 SEE SECTION H10 50382903679602

Patients

Seq Age Sex Outcome Treatment
1 Unknown